ABVX
Abivax SA
NASDAQ · Healthcare · Biotechnology · FR
$105.04
−1.82%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-73.9%
Return on equity
-51.5%
Return on assets
-49.1%
Return on invested capital
0.00x
Asset turnover
-$120.1M
Cash from operations
$6.97
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025